
Maharashtra FDA Cancels Cipla Pune Warehouse Licences Over Drug Lapses
The story in brief
Maharashtra FDA revoked Cipla Pharma & Life Sciences’ Pune warehouse drug licences due to misbranding and storage lapses. The cancellation followed High Court directions in Writ Petition No. 11376/2026, impacting Pune’s medicine supply and Cipla’s operations. Cipla failed to provide required records and faced discrepancies between digital and physical stock.